EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema

詳細情報 詳細情報について

• CRID

  1360855568560612608

• DOI

  10.1016/j.anai.2010.04.012

• ISSN

  10811206

• Web Site

  https://api.elsevier.com/content/article/PII:S1081120610004229?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S1081120610004229?httpAccept=text/plain

• データソース種別

  • Crossref